Approval · Notice of Compliance 8899 · 2007
CYSTADANE: Notice of Compliance 8899
Issued July 10, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8899
- Date
- July 10, 2007
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the product monograph: changes to dosage and administration for pediatric patients
- Therapeutic class
- Anti-homocysteine agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CYSTADANE | Not yet assigned | — |
Medicinal ingredients
- BETAINE 1 G